Undervalued Medical Diagnostic & Research Stocks on NAS May 2025

May 18, 2025

Medical Diagnostics & Research

Medical Diagnostics & Research companies provide laboratory testing services through imaging and other diagnostic services to the medical industry.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Medical Diagnostics & Research stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
NEOG Neogen 6.61 16.16 144.51 7169865 1435 0.00 0.0
MYNZ Mainz Biomed 2.44 5.63 130.73 299111 2 0.00 0.0
BIAF bioAffinity Technologies 0.21 0.43 102.54 1305263 3 0.00 0.0
BNR Burning Rock Biotech 2.85 5.26 84.71 66816 29 0.00 0.0
STRR Star Equity Hldgs 2.31 3.83 65.65 22196 7 0.00 0.0
MYGN Myriad Genetics 4.13 6.76 63.75 3374334 377 0.00 0.0
NEO NeoGenomics 8.11 11.96 47.53 2975664 1033 0.00 0.0
OPK OPKO Health 1.33 1.92 44.17 3605611 893 0.00 0.0
XWEL XWELL 0.91 1.27 39.28 111204 4 0.00 0.0
BDSX Biodesix 0.30 0.35 16.78 3562589 39 0.00 0.0
All data provided as at market close May 15, 2025.

Company Details

Neogen

NEOG:NAS

Close Price

6.61

Our Valuation

16.16

% Difference

144.51

Market Cap ($M)

1435

P/E Ratio

0.0

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines.

Access the stockcalc valuation


Mainz Biomed

MYNZ:NAS

Close Price

2.44

Our Valuation

5.63

% Difference

130.73

Market Cap ($M)

2

P/E Ratio

0.0

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Access the stockcalc valuation


bioAffinity Technologies

BIAF:NAS

Close Price

0.21

Our Valuation

0.43

% Difference

102.54

Market Cap ($M)

3

P/E Ratio

0.0

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Access the stockcalc valuation


Burning Rock Biotech

BNR:NAS

Close Price

2.85

Our Valuation

5.26

% Difference

84.71

Market Cap ($M)

29

P/E Ratio

0.0

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Star Equity Hldgs

STRR:NAS

Close Price

2.31

Our Valuation

3.83

% Difference

65.65

Market Cap ($M)

7

P/E Ratio

0.0

Star Equity Holdings Inc is a multi-industry diversified holding company.

Access the stockcalc valuation


Myriad Genetics

MYGN:NAS

Close Price

4.13

Our Valuation

6.76

% Difference

63.75

Market Cap ($M)

377

P/E Ratio

0.0

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer.

Access the stockcalc valuation


NeoGenomics

NEO:NAS

Close Price

8.11

Our Valuation

11.96

% Difference

47.53

Market Cap ($M)

1033

P/E Ratio

0.0

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Access the stockcalc valuation


OPKO Health

OPK:NAS

Close Price

1.33

Our Valuation

1.92

% Difference

44.17

Market Cap ($M)

893

P/E Ratio

0.0

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations.

Access the stockcalc valuation


XWELL

XWEL:NAS

Close Price

0.91

Our Valuation

1.27

% Difference

39.28

Market Cap ($M)

4

P/E Ratio

0.0

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products.

Access the stockcalc valuation


Biodesix

BDSX:NAS

Close Price

0.30

Our Valuation

0.35

% Difference

16.78

Market Cap ($M)

39

P/E Ratio

0.0

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Neogen and Mainz Biomed are the most undervalued Medical Diagnostics & Research stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-diagnostic-research-stocks-nas-may-2025
Neogen $NEOG and Mainz Biomed $MYNZ are the most undervalued Medical Diagnostics & Research stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-medical-diagnostic-research-stocks-nas-may-2025
Neogen and Mainz Biomed are the most undervalued Medical Diagnostics & Research stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-diagnostic-research-stocks-nas-may-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.